Literature DB >> 25469209

DNMT3A: the DioNysian MonsTer of acute myeloid leukaemia.

Emma Conway O'Brien1, John Brewin1, Timothy Chevassut2.   

Abstract

In the mythology of Ancient Greece, there was often a creative tension between the opposing forces of the gods Apollo and Dionysius, the two sons of Zeus. The Apollonian force was considered to be rational and lifegiving, whilst Dionysian forces were chaotic and elemental. Acute myeloid leukaemia is characterised by the clash of these forces: the chaotic proliferation of immature myeloid cells in the bone marrow overcomes the normal, orderly production of healthy blood cells. DNMT3A mutations occur early in the leukaemogenic process and may even act as "founder" mutations - the first step in a pathway towards malignant transformation. As such, these mutations may represent a Dionysian agent of disorder, inciting the chaotic myeloid proliferation and arrest of differentiation which are hallmarks of AML. This review will focus on the role of DNMT3A mutations in leukaemia pathogenesis, their influence on prognosis, and the potential for therapeutic targeting.

Entities:  

Keywords:  AML; DNMT3A; acute myeloid leukaemia; prognosis

Year:  2014        PMID: 25469209      PMCID: PMC4250269          DOI: 10.1177/2040620714554538

Source DB:  PubMed          Journal:  Ther Adv Hematol        ISSN: 2040-6207


  64 in total

1.  The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers.

Authors:  David A Russler-Germain; David H Spencer; Margaret A Young; Tamara L Lamprecht; Christopher A Miller; Robert Fulton; Matthew R Meyer; Petra Erdmann-Gilmore; R Reid Townsend; Richard K Wilson; Timothy J Ley
Journal:  Cancer Cell       Date:  2014-03-20       Impact factor: 31.743

2.  Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine.

Authors:  William Blum; Ramiro Garzon; Rebecca B Klisovic; Sebastian Schwind; Alison Walker; Susan Geyer; Shujun Liu; Violaine Havelange; Heiko Becker; Larry Schaaf; Jon Mickle; Hollie Devine; Cheryl Kefauver; Steven M Devine; Kenneth K Chan; Nyla A Heerema; Clara D Bloomfield; Michael R Grever; John C Byrd; Miguel Villalona-Calero; Carlo M Croce; Guido Marcucci
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-05       Impact factor: 11.205

3.  DNA methyltransferases control telomere length and telomere recombination in mammalian cells.

Authors:  Susana Gonzalo; Isabel Jaco; Mario F Fraga; Taiping Chen; En Li; Manel Esteller; María A Blasco
Journal:  Nat Cell Biol       Date:  2006-03-26       Impact factor: 28.824

4.  Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia.

Authors:  S Deneberg; M Grövdal; M Karimi; M Jansson; H Nahi; A Corbacioglu; V Gaidzik; K Döhner; C Paul; T J Ekström; E Hellström-Lindberg; S Lehmann
Journal:  Leukemia       Date:  2010-03-18       Impact factor: 11.528

Review 5.  The role of mutations in epigenetic regulators in myeloid malignancies.

Authors:  Alan H Shih; Omar Abdel-Wahab; Jay P Patel; Ross L Levine
Journal:  Nat Rev Cancer       Date:  2012-08-17       Impact factor: 60.716

6.  DNMT3A mutations in acute myeloid leukemia.

Authors:  Timothy J Ley; Li Ding; Matthew J Walter; Michael D McLellan; Tamara Lamprecht; David E Larson; Cyriac Kandoth; Jacqueline E Payton; Jack Baty; John Welch; Christopher C Harris; Cheryl F Lichti; R Reid Townsend; Robert S Fulton; David J Dooling; Daniel C Koboldt; Heather Schmidt; Qunyuan Zhang; John R Osborne; Ling Lin; Michelle O'Laughlin; Joshua F McMichael; Kim D Delehaunty; Sean D McGrath; Lucinda A Fulton; Vincent J Magrini; Tammi L Vickery; Jasreet Hundal; Lisa L Cook; Joshua J Conyers; Gary W Swift; Jerry P Reed; Patricia A Alldredge; Todd Wylie; Jason Walker; Joelle Kalicki; Mark A Watson; Sharon Heath; William D Shannon; Nobish Varghese; Rakesh Nagarajan; Peter Westervelt; Michael H Tomasson; Daniel C Link; Timothy A Graubert; John F DiPersio; Elaine R Mardis; Richard K Wilson
Journal:  N Engl J Med       Date:  2010-11-10       Impact factor: 91.245

7.  MeDIP coupled with a promoter tiling array as a platform to investigate global DNA methylation patterns in AML cells.

Authors:  Arzu Yalcin; Clemens Kreutz; Dietmar Pfeifer; Mahmoud Abdelkarim; Gregor Klaus; Jens Timmer; Michael Lübbert; Björn Hackanson
Journal:  Leuk Res       Date:  2012-10-11       Impact factor: 3.156

8.  Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia.

Authors:  Jan Krönke; Lars Bullinger; Veronica Teleanu; Florian Tschürtz; Verena I Gaidzik; Michael W M Kühn; Frank G Rücker; Karlheinz Holzmann; Peter Paschka; Silke Kapp-Schwörer; Daniela Späth; Thomas Kindler; Marcus Schittenhelm; Jürgen Krauter; Arnold Ganser; Gudrun Göhring; Brigitte Schlegelberger; Richard F Schlenk; Hartmut Döhner; Konstanze Döhner
Journal:  Blood       Date:  2013-05-23       Impact factor: 22.113

9.  Leukemic evolution of donor-derived cells harboring IDH2 and DNMT3A mutations after allogeneic stem cell transplantation.

Authors:  T Yasuda; T Ueno; K Fukumura; A Yamato; M Ando; H Yamaguchi; M Soda; M Kawazu; E Sai; Y Yamashita; M Murata; H Kiyoi; T Naoe; H Mano
Journal:  Leukemia       Date:  2013-09-26       Impact factor: 12.883

Review 10.  DNA methyltransferases: a novel target for prevention and therapy.

Authors:  Dharmalingam Subramaniam; Ravi Thombre; Animesh Dhar; Shrikant Anant
Journal:  Front Oncol       Date:  2014-05-01       Impact factor: 6.244

View more
  4 in total

1.  Quantitative detection of DNMT3A R882H mutation in acute myeloid leukemia.

Authors:  Rimma Berenstein; Igor Wolfgang Blau; Nikola Suckert; Claudia Baldus; Antonio Pezzutto; Bernd Dörken; Olga Blau
Journal:  J Exp Clin Cancer Res       Date:  2015-05-22

2.  Diagnostic and Prognostic Power of Active DNA Demethylation Pathway Intermediates in Acute Myelogenous Leukemia and Myelodysplastic Syndromes.

Authors:  Aleksandra Skalska-Bugala; Marta Starczak; Łukasz Szukalski; Maciej Gawronski; Agnieszka Siomek-Gorecka; Justyna Szpotan; Anna Labejszo; Ewelina Zarakowska; Anna Szpila; Anna Jachalska; Adriana Szukalska; Marcin Kruszewski; Anna Sadowska; Aleksandra Wasilow; Patrycja Baginska; Jaroslaw Czyz; Ryszard Olinski; Rafal Rozalski; Daniel Gackowski
Journal:  Cells       Date:  2022-03-04       Impact factor: 6.600

3.  MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia.

Authors:  Ashujit Tagde; Hasan Rajabi; Dina Stroopinsky; Reddy Gali; Maroof Alam; Audrey Bouillez; Surender Kharbanda; Richard Stone; David Avigan; Donald Kufe
Journal:  Oncotarget       Date:  2016-06-28

4.  Functional Analysis of DNMT3A DNA Methyltransferase Mutations Reported in Patients with Acute Myeloid Leukemia.

Authors:  Daria A Khrabrova; Andrei G Loiko; Anastasia A Tolkacheva; Natalia A Cherepanova; Maria I Zvereva; Olga V Kirsanova; Elizaveta S Gromova
Journal:  Biomolecules       Date:  2019-12-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.